GLYC - GlycoMimetics Inc. (GLYC) CEO Rachel King on Q1 2021 Results - Earnings Call Transcript

GlycoMimetics, Inc. (GLYC) Q1 2021 Earnings Conference Call May 3, 2021 08:30 ET Company Participants Shari Annes - Investor Relations Rachel King - Chief Executive Officer Brian Hahn - Chief Financial Officer John Magnani - Chief Scientific Officer Eric Feldman - Chief Medical Officer Conference Call Participants Stephen Willey - Stifel Zegbeh Jallah - ROTH Capital Partners Steve Bersey - H.C. Wainwright Jason Bouvier - Jefferies Presentation Operator Good morning and thank you for joining the GlycoMimetics Call. At this time, all participants are in listen-only mode. Following management’s remarks, we will hold a question-and-answer session. [Operator Instructions] I would now like to turn the call over to Shari Annes of Investor Relations Group at GlycoMimetics. Please go ahead. Shari Annes Good morning. Today, we will review our accomplishments and financial results for the period ended March 31, 2021. We will also update you on recent achievements. The press release

For further details see:

GlycoMimetics, Inc. (GLYC) CEO Rachel King on Q1 2021 Results - Earnings Call Transcript